Brian Ballard Denies White House Influence Claims as Calley Means Targets 2 K Street Firms
Updated
Updated · POLITICO · Nov 9
Brian Ballard Denies White House Influence Claims as Calley Means Targets 2 K Street Firms
1 articles · Updated · POLITICO · Nov 9
Summary
Ballard issued a weekend statement rejecting Calley Means’ claims that Ballard Partners used improper access to sway Trump White House policy on fruit-flavored vapes and glyphosate-based herbicides.
Means, who left the administration last month after serving as a senior adviser to Health Secretary Robert F. Kennedy Jr., escalated the fight by saying Susie Wiles “and her friends” represent corruption and corporate capture.
The White House said it has never allowed outside groups to influence policy decisions, while Ballard said contacts with Chief of Staff Wiles were limited and mostly outside the West Wing.
Ballard Partners’ Bayer filing reported lobbying the “White House Office” on crop-protection issues, though a firm partner said that category covers hundreds of executive-office staff and did not specifically reference glyphosate.
The clash opens a fresh K Street fault line around Trump-world influence and could make Ballard Partners a Democratic oversight target next year as lawmakers scrutinize special-interest access.